Strategies in the development of vaccines to prevent infections with group A streptococcus

Long-Term Antibody Memory Induced by Synthetic Peptide Vaccination Is Protective against Streptococcus pyogenes Infection and Is Independent of Memory T Cell Help

(2013) M. Pandey et al.   JOURNAL OF IMMUNOLOGY

Conserved anchorless surface proteins as group A streptococcal vaccine candidates

(2012) Anna Henningham et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

A Human PrM Antibody That Recognizes a Novel Cryptic Epitope on Dengue E Glycoprotein

(2012) Annie Hoi Yi Chan et al.   PLoS One

Evaluation of novel Streptococcus pyogenes vaccine candidates incorporating multiple conserved sequences from the C-repeat region of the M-protein

(2012) Michelle J. Bauer et al.   VACCINE

New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci

(2011) James B. Dale et al.   VACCINE

A Strategy for Eliciting Antibodies against Cryptic, Conserved, Conformationally Dependent Epitopes of HIV Envelope Glycoprotein

(2010) Hanna C. Kelker et al.   PLoS One

emm and C-Repeat Region Molecular Typing of Beta-Hemolytic Streptococci in a Tropical Country: Implications for Vaccine Development

(2009) A. C. Steer et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Comprehensive analysis of antibody responses to streptococcal and tissue antigens in patients with acute rheumatic fever

(2008) T. B. Martins et al.   INTERNATIONAL IMMUNOLOGY

Genetic diversity of Group A Streptococcus M protein: Implications for typing and vaccine development

(2008) Pierre R. Smeesters et al.   VACCINE